A. Head et al., EXERCISE METABOLISM IN HEALTHY-VOLUNTEERS TAKING CELIPROLOL, ATENOLOL, AND PLACEBO, British journal of sports medicine, 31(2), 1997, pp. 120-125
Objective-Previous studies have show that beta(1) selective agents hav
e fewer adverse effects on exercise metabolism than non-selective beta
blockers, and this has been attributed to their reduced blockade of b
eta(2) receptors. This study aimed at determining whether a beta block
er with partial agonist activity at beta(1) and beta(2) receptors (cel
iprolol) was better than a conventional beta(1) receptor-blocker (aten
olol) in prolonging exercise capabilities. Methods-After four days of
treatment with celiprolol 200 mg, atenolol 50 mg, or placebo, 22 healt
hy volunteers exercised on a treadmill for two hours at 50% of their m
aximal oxygen uptake. Resting heart rate and blood pressure were recor
ded before and after exercise. During exercise, fat oxidation, plasma
free fatty acids, glycerol, glucose, and ammonia were measured togethe
r with heart rate and perceived exertion. Results-Mean exercising hear
t rate was significantly lower in those taking either of the beta bloc
kers than in those taking placebo, and significantly lower for those t
aking atenolol rather than celiprolol. Fat oxidation was significantly
lower for those taking celiprolol (38.8 (SD 12.2)%, P<0.01) and ateno
lol (36.6 (15.9)%, P<0.01) compared with placebo (45.6 (14.1)%). For t
he first 15 minutes of exercise, fat oxidation was significantly lower
for those taking atenolol (24.6 (12.8)%, P<0.01) than celiprolol (29.
6 (14.3)%). The rise in plasma free fatty acids and glycerol during ex
ercise was also significantly attenuated by both beta blockers in comp
arison with the rise in those taking placebo (P<0.01). Conclusions-Bot
h celiprolol and atenolol reduced fat oxidation compared with placebo.
For the first 15 minutes of exercise fat oxidation was preserved by c
eliprolol, but not atenolol. This preservation of fat oxidation during
the early part of exercise may confer some small benefit to patients
who take beta blockers and intend to exercise regularly. However, we d
id not detect significant differences between atenolol and celiprolol
in overall mean fat oxidation or perceived exertion in this study.